Диссертация (1139549), страница 25
Текст из файла (страница 25)
- Vol. 178-3: 511-515.128. Centers for Disease Control and Prevention. 2011 sexually transmitteddiseases surveillance.129. Clinical Effectiveness Group (British Association for Sexual Health andHIV). United Kingdom National Guideline on the Management of Anogenital Warts.- 2007.130. Committee for proprietary medicinal products (CPMP) (2000) Points toConsider on Switching Between Superiority and Non-Inferiority. London, 27 July2000. CPMP/EWP/482/99.131. Cornall A.M., Roberts J.M., Garland S.M., et al. Anal and perianal181squamous carcinomas and high-grade intraepithelial lesions exclusively associatedwith “low-risk" HPV genotypes 6 and 11 // Int J Cancer 2013;133(9):2253-8.132. Curlin M., Bursac D.
Cervical mucus: from biochemical structure toclinical implications // Front Biosci (Schol Ed). - 2013 Jan 1;5: 507-15.133. Debattista J., Timms P., Allan J., Allan J. Immunopathogenesis ofchlamydia trachomatis infections in women. Fertil Steril 2003; 79:1273.134. Dinh T.-H., Sternberg M., Dunne E.F., et al. Genital warts among 18-to59-year-olds in the United States, national health and nutrition examination survey,1999-2004 // Sex Transm Dis 2008;35(4):357-60.135. Easmon C.S., Hay P.E., Ison C.A. Bacterial vaginosis: a diagnosticapproach // Genitourin Med 1992 April; 68: 134-8.136. Effect Of Box-Cox Transformation On Genetic Parameter Estimation InLayers. URL: http://ziraat.ege.edu.tr/~yakbas/yayin/sunumout/out10.pdf/.137.
Embree J., Caliando J.J., McCormack W.M. Nonspecific vaginitis amongwomen attending a sexually transmitted diseases clinic // Sex Transm Dis1984;11:81-4.138. Fahrbach K.M., Malykhina O., Stieh D.J., Hope T.J. Differential bindingof IgG and IgA to mucus of the female reproductive tract // PLoS One. 2013 Oct2;8(10):e76176.139. Fethers K.A., Fairley C.K., Hocking J.S., Gurrin L.C., Bradshaw C.S.Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis //Clin Infect Dis 2008 December 1; 47: 1426-35.140.
Fethers K.A., Fairley C.K., Morton A., et al. Early sexual experiencesand risk factors for bacterial vaginosis // J Infect Dis 2009; 200: 1662-70.141. Fischbach F., Petersen E.E., Weissenbacher E.R., et al. Efficacy ofclindamycin vaginal cream versus oral metronidazole in the treatment of bacterialvaginosis // Obstet Gynecol. 1993 Sep;82(3):405-10.142. Franco E.L., Villa L.L., Richardson H., Rohan T.E., Ferenczy A.Epidemiology of cervical human papillomavirus infection // New Developments inCervical Cancer Screening and prevention. Oxford: Blackwell Science.
- 1997:14-22.182143. Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification ofbacteria associated with bacterial vaginosis // N Engl J Med 2005 November 3; 353:1899-911.144. Frohlich K.M., Hua Z., Quayle A.J., et al. Membrane vesicle productionby Chlamydia trachomatis as an adaptive response // Front Cell Infect Microbiol. 2014(4):73.145. Gaelle Boncompain, et al. The Intracellular bacteria chlamydia hijackperoxisomes and utilize their enzymatic capacity to produce bacteria-specificphospholipids.
PloS one, 2014; 1-9.146. Garland S.M., Steben M., Sings H.L., et al. Natural history of genitalwarts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalenthuman papillomavirus (types 6,11,16, and 18) vaccine // J Infect Dis2009;199(6):805-14.147. Garland S.M., Waddell R., Mindel A., Denham I.M., McCloskey J.C. Anopen-label phase II pilot study investigating the optimal duration of imiquimod 5%cream for the treatment of external genital warts in women // Int J STD & AIDS2006;17:448-52.148.
Genser B., Cooper P.J., Yazdanbakhsh M., Barreto M.L., Rodrigues L.C.A guide to modern statistical analysis of immunological data. BMC Immunol.2007;8:27. URL: http://www.biomedcentral.com/1471-2172/8/27.149. Godley M.J., Bradbeer C.S., Gellan M., et al. Cryotherapy comparedwith trichloracetic acid in treating genital warts // Genitourin Med 1987;63:390-2.150. Hariri S., Dunne E.,Saraiya M., Unger E., Markowitz L.
Manual for theSurveillance of Vaccine-Preventable Diseases. Chapter 5: Human Papillomavirus. VPD Surveillance Manual, 5th Edition, 2011.151. Hay P., Patel S., Daniels D. UK national guideline for the managementof bacterial vaginosis. - 2012.152. Horner P.J., Boag F.
2006 UK national guideline for the management ofgenital tract infection with Chlamydia trachomatis. London (UK): British Associationof Sexual Health and HIV (BASHH); 2006.183153. Kägebein D., Gutjahr M., Große C., Vogel A.B., Rödel J., Knittler M.R.Chlamydia trachomatis-infected epithelial cells and fibroblasts retain the ability toexpress surface-presented major histocompatibility complex class I molecules //Infect Immun. 2014 Mar;82(3):993-1006.154. Kamb M.L.
Cervical cancer screening of women attending STD clinics /M.L. Kamb // Clinical Infectious diseases. 1995. Vol. 20. № 1: 98-103.155. Khaskheli M., Baloch S., Baloch, A. S. Obstetrical trauma to the genitaltract following vaginal delivery. J Coll Physicians Surg Pak, 2012 (22): 95-97.156. Kjær S.K., Nam T.T., Sparen P., et al. The burden of genital warts: astudy of nearly 70,000 women from the general female population in the 4 Nordiccountries // J Infect Dis 2007;196(10):1447-54157. Klatt T.E., Cole D.C., Eastwood D.C., Barnabei V.M. Factors associatedwith recurrent bacterial vaginosis // Journal of Reproductive Medicine.
2010;55(1-2):55-61.158. Klebanoff M.A., Schwebke J.R., Zhang J., Nansel T.R., Yu K.-F.,Andrews W.W. Vulvovaginal symptoms in women with bacterial vaginosis //Obstetrics and Gynecology. - Volume 104, Issue 2, August 2004: 267-272.159. Komericki P., Akkilic-Materna M., Strimitzer T., Aberer W. Efficacy andsafety of imiquimod versus podophyllotoxin in the treatment of genital warts // SexTransm Dis 2011;38:216-8.160. Koumans E.H., Markowitz L.E., Hogan V. Indications for therapy andtreatment recommendations for bacterial vaginosis in nonpregnant and pregnantwomen: a synthesis of data // Clin Infect Dis 2002 October 15; 35(suppl 2): 152-72.161.
Koutsky L.A., Kiviar N.B. Genital human papilomavirus. In: SexualTransmitted Diseases/ Ed. K. K. Holmes, et al. -3rd ed. - Mc.Growhill., 1999.162. Lacey C.J.N. et al. 2012 European guideline for the management ofanogenital warts // Journal of the European Academy of Dermatology andVenereology. – 2013. - 27. - № 3. – С. 263-270.163. Lanjouw E., et al. European guideline for the management of Chlamydiatrachomatis infections. International journal of STD & AIDS 21.11 (2010): 729-737.184164.
Lesaffre E. Equivalence, and Non-Inferiority Trials// Bulletin of theNYU Hospital for Joint Diseases 2008;66(2):150-4.165. Louise M. Hafner, Trudi A. Collet, Danica K. Hickey. Immuneregulation of Chlamydia trachomatis infections of the female genital tract//Immunostimulation. 2014: 177-208.166.
Low N., Cassell J.A., Spencer B., et al. Chlamydia control activities inEurope: cross-sectional survey. European Journal of Public Health. 2012;22(4):556561.167. Markos A.R. The concordance of Chlamydia trachomatis genitalinfection between sexual partners, in the era of nucleic acid testing // Sex Health. 2005;2:23-24.168. Mayberry-Carson K.J., Tober-Meyer B., Lambe D.W. Jr., Costerton J.W.An electron microscopic study of the effect of clindamycin therapy on bacterialadherence and glycocalyx formation in experimental Staphylococcus aureusosteomyelitis // Microbios. 1986;48(196-197):189-206.169.
McDonald H.M., Brocklehurst P., Gordon A. Antibiotics for treatingbacterial vaginosis in pregnancy // Cochrane Database Syst Rev 2007; (1):CD000262.170. McDonald H.M., O'Loughlin J.A., Vigneswaran R., Jolley P.T., HarveyJ.A., Bof A. et al. Impact of metronidazole therapy on preterm birth in women withbacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlledtrial // Br J Obstet Gynaecol 1997 December;104(12):1391-7.171. McGuinness D., Bennett S., Riley E. Statistical analysis of highlyskewed immune response data. J Immunol Methods 1997, 201:99-114.172. Mena´rguezM.,PastorL.M.,OdebladE.Morphologicalcharacterization of different human cervical mucus types using light and scanningelectron microscopy.
Hum. Reprod. 2003 (18): 1782-1789.173. Mylonas I. Female genital Chlamydia trachomatis infection: where arewe heading? // Arch Gynecol Obstet. 2012;285:1271-85.174. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial185vaginosis is improved by a standardized method of gram stain interpretation // J ClinMicrobiol. 1991 Feb;29(2):297-301.175.
Oriel J. Natural history of genital warts // Br J Vener Dis 1971;47(1):1.176. Osborne J.W. Improving your data transformations: Applying the BoxCox transformation. Practical Assessment, Research & Evaluation. Vol. 15, Number12, October, 2010. URL: http://pareonline.net/pdf/v15n12.pdf.177.
Paavonen J. Chlamydia trachomatis infections of the female genital tract:state of the art // Ann Med 2012, 44(1):18-28.178. Patel H., Wagner M., Singhal P., et al. Systematic review of theincidence and prevalence of genital warts // BMC Infect. Dis. – 2013; 13: 39.179. PatelR.V., Yanofsky V.R.,GoldenbergG.Genitalwarts:acomprehensive review // J Clin Aesthet Dermatol 2012;5(6):25.180. Pirotta M., Stein A.N., Conway E.L., et al.
Genital warts incidence andhealthcare resource utilisation in Australia // Sex Transm Infect 2010;86(3):18-16.181. Reid G., et al. The rationale for probiotics in female urogenitalhealthcare // Med Gen Med 2004;6(1):49.182. Rours G.I., et al. Chlamydia trachomatis infection during pregnancyassociated with preterm delivery: a population-based prospective cohort study // Eur JEpidemiol. 2011;26(6): 493-502.183. Sarah C. Woodhall, Katherine M.E. Turner, Gwenda Hughes.Maximising the effectiveness of the National Chlamydia Screening Programme inEngland: should we routinely retest positives?.
Sexually transmitted infections, 89(1),2013: 2-3.184. Schmitt C., Sobel J.D., Meriwether C. Bacterial vaginosis: treatmentwith clindamycin cream versus oral metronidazole // Obstet Gynecol. 1992Jun;79(6):1020-3.185. Sherrard J., Donders G., White D., et al. European (IUSTI/WHO)guideline on the management of vaginal discharge, 2011. Int J STD AIDS 2011;22:421.186. Sherrard J., Riddell L. Comparison of the effectiveness of commonly186used clinic-based treatments for external genital warts // Int J STD & AIDS2007;18:365-8.187. Shi H., Zhang X., Ma C., et al. Clinical analysis of five methods used totreat condylomata acuminata // Dermatology.
- 2013;227(4):338-45.188. Singh M., Chaudhry P., Asselin E. Bridging endometrial receptivity andimplantation: network of hormones, cytokines, and growth factors // J Endocrinol. 2011 Jul; 210(1): 5-14.189. Siqueira L.M. Chlamydia infections in children and adolescents //Pediatrics in Review 35(4). - 2014: 145-154.190. Stanley M.A. Immune responses to human papilloma viruses // Indian JMed Res. - 2009 Sep; 130(3): 266-76.191.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
